蝴蝶效应迅速发生,Merrimack公司在有权获得大额里程碑付款后,鉴于公司预计不会收到除此之外的...查看全文
Merrimack(MACK)03-06 05:45
$Merrimack制药(MACK)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-059357 Act: 34 Size: 1 MB 网页链接查看全文
Merrimack(MACK)03-28 05:05
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-078910 Act: 34 Size: 194 KB 网页链接查看全文
Merrimack(MACK)03-28 05:05
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-078920 Act: 34 Size: 53 KB 网页链接查看全文
Merrimack(MACK)03-22 21:55
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-074722 Act: 34 Size: 56 KB 网页链接查看全文
Merrimack(MACK)02-14 05:25
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-033761 Act: 34 Size: 202 KB 网页链接查看全文
Merrimack(MACK)03-08 01:35
$Merrimack制药(MACK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-007251 Act: 34 Size: 12 KB 网页链接查看全文
Merrimack(MACK)03-08 05:25
$Merrimack制药(MACK)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-027966 Act: 34 Size: 5 MB 网页链接查看全文
Merrimack(MACK)03-08 05:45
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-062260 Act: 34 Size: 187 KB 网页链接查看全文
Merrimack(MACK)03-08 05:45
$Merrimack制药(MACK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-24-062268 Act: 34 Size: 49 KB 网页链接查看全文
智通财经APP获悉,周三,美国生物技术公司Merrimack Pharma(MACK.US)的法国癌症治疗合作伙伴Ipsen S.A.宣布,其药物Onivyde作为一种组合疗法,在一种胰腺癌的后期试验中达到了主要终点。截至发稿,Merrimack Pharma盘前涨238.75%,报13.... 网页链接
$Merrimack(MACK)$ DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001193125-24-083441 Act: 34 Size: 619 KB 网页链接
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-078910 Act: 34 Size: 194 KB 网页链接
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-078920 Act: 34 Size: 53 KB 网页链接
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-074722 Act: 34 Size: 56 KB 网页链接
$Merrimack制药(MACK)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-073941 Act: 34 Size: 970 KB 网页链接
$Merrimack制药(MACK)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-073929 Act: 34 Size: 458 KB 网页链接
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-062260 Act: 34 Size: 187 KB 网页链接
$Merrimack制药(MACK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-24-062268 Act: 34 Size: 49 KB 网页链接
$Merrimack制药(MACK)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-027966 Act: 34 Size: 5 MB 网页链接
$Merrimack制药(MACK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-007251 Act: 34 Size: 12 KB 网页链接